In rheumatoid arthritis (RA), PADI4 increases thrombin activity by citrullinating antithrombin, and thereby affects the vascular endothelial cells proliferation and RA synovial tissue inflammation [26, 27]. This evidence concerns the gene PADI4 and rheumatoid arthritis.